CPH Pharma ApS: Financial statements 2019
CVR: 37110248
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
CPH Pharma ApS (CVR 37110248) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 798,671 and a net result of DKK 574,647 compared with DKK -419,887 the year before. Equity in the 2019 report amounted to DKK -32,612. The company had 1 employee in the financial year.
- Gross Profit
- DKK 798,671
- Profit/Loss
- DKK 574,647
- Equity
- DKK -32,612
- Total Assets
- DKK 713,792
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 799 t. | 575 t. | -33 t. | 1 |
| 2018 | - | -104 t. | -420 t. | -607 t. | 1 |
| 2017 | - | 80 t. | -196 t. | -187 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
CPH Pharma ApS has published its annual report for 2018. Gross profit came to DKK -103,613, and the net result was DKK -419,887.
About CPH Pharma ApS
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.